- Report
- August 2024
- 148 Pages
Global
From €2730EUR$2,999USD£2,318GBP
- Report
- August 2024
- 148 Pages
Global
From €2730EUR$2,999USD£2,318GBP
- Report
- July 2024
- 137 Pages
Global
From €2730EUR$2,999USD£2,318GBP
- Report
- July 2024
- 146 Pages
Global
From €2730EUR$2,999USD£2,318GBP
- Report
- July 2024
- 135 Pages
Global
From €2730EUR$2,999USD£2,318GBP
- Report
- December 2024
- 206 Pages
Global
From €2275EUR$2,500USD£1,933GBP
- Report
- August 2024
- 168 Pages
Global
From €2275EUR$2,500USD£1,933GBP
- Report
- January 2025
- 182 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- December 2024
- 186 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- August 2024
- 187 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- May 2024
- 183 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- May 2024
- 185 Pages
Global
From €4096EUR$4,500USD£3,479GBP
- Report
- April 2025
- 200 Pages
Global
From €4087EUR$4,490USD£3,471GBP
- Report
- December 2024
- 175 Pages
Global
From €4551EUR$5,000USD£3,865GBP
- Report
- April 2025
- 126 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- April 2025
- 120 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- April 2025
- 120 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- April 2025
- 120 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- April 2025
- 110 Pages
Global
From €4323EUR$4,750USD£3,672GBP
- Report
- April 2025
- 100 Pages
Global
From €4323EUR$4,750USD£3,672GBP

The Contract Research market within the context of Drug Discovery is a rapidly growing industry that provides services to pharmaceutical and biotechnology companies. These services include preclinical and clinical research, drug development, and manufacturing. Contract Research Organizations (CROs) provide a range of services to support drug discovery, such as preclinical and clinical trial design, data management, regulatory affairs, and drug safety. CROs also provide services such as drug formulation, drug delivery, and drug manufacturing.
CROs are increasingly being used to reduce the cost and time associated with drug discovery and development. They provide access to specialized expertise and resources, as well as the ability to scale up quickly. This allows companies to focus on their core competencies and reduce the risk associated with drug development.
Some companies in the Contract Research market include Parexel, Quintiles, Covance, Charles River Laboratories, and PPD. Show Less Read more